Teams at Summit Therapeutics, Inc.

Lead upstream MSAT activities for mAb drug substance: drive technology transfers, process characterization, PPQ/CPV, lifecycle and change control, regulatory Module 3 support, inspection readiness, and commercial manufacturing oversight.

Lead downstream MSAT activities for biologics (ivonescimab), providing technical oversight of process development, validation, tech transfers to CDMOs, troubleshooting, change control, and regulatory support. Collaborate cross-functionally to ensure robust scale-up, continuous process verification, and successful CMC deliverables.

The VP of US Marketing will develop the marketing strategy for ivonescimab, oversee launch readiness, and drive brand growth, including KPI management and team development.